Behavioral Intervention

Treatment for Rumination Syndrome

Teachers College, Columbia University, New York, NY
Targeting 6 different conditionsEmotion Regulation Therapy via TelehealthN/ARecruitingLed by Douglas S MenninResearch Sponsored by Teachers College, Columbia University

Study Summary

This trial looks at how therapy over video can help reduce worry, rumination, and self-criticism in NYers.

Eligible Conditions
  • Rumination Syndrome
  • Self-Criticism
  • Anxiety
  • Depression
  • Emotional Distress

Eligibility Criteria

Inclusion Criteria

You will be eligible if you check “Yes” for the criteria below
You often feel very worried, think about things too much, or are very hard on yourself.


Screening ~ 3 weeks
Treatment ~ Varies
Follow ups ~ weekly from baseline (2 weeks) through treatment (12 weeks) and follow-up (4 weeks)
This trial's timeline: 3 weeks for screening, Varies for treatment, and weekly from baseline (2 weeks) through treatment (12 weeks) and follow-up (4 weeks) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Weekly Assessment of Change in Attentional Control
Corneal Opacity
Weekly Assessment of Change in Decentering
+2 more
Secondary outcome measures
Mental Depression
Weekly Assessment of Change in Rumination
+2 more
Other outcome measures
Weekly Assessment of Change in Behavioral Regulation
Weekly Assessment of Change in Disability/Impairment
Weekly Assessment of Change in Life Satisfaction

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: TreatmentExperimental Treatment1 Intervention
All participants will receive a 12-session version of Emotion Regulation Therapy delivered weekly via synchronous telehealth using videoconferencing software and an asynchronous Internet-based online platform to supplement the content covered in each session.

Find a site

Who is running the clinical trial?

Teachers College, Columbia UniversityLead Sponsor
23 Previous Clinical Trials
3,345 Total Patients Enrolled
Douglas S MenninPrincipal Investigator
Professor of Clinical Psychology

Media Library

Emotion Regulation Therapy via Telehealth (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05590741 — N/A
Rumination Syndrome Research Study Groups: Treatment
Rumination Syndrome Clinical Trial 2023: Emotion Regulation Therapy via Telehealth Highlights & Side Effects. Trial Name: NCT05590741 — N/A
Emotion Regulation Therapy via Telehealth (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05590741 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this trial provide an opportunity for individuals aged 40 and over to participate?

"As stated in the criteria for inclusion, applicants must be aged 18-65 to take part in this clinical trial."

Answered by AI

Is it feasible for me to partake in this trial?

"Eligible participants of this clinical trial must present with a diagnosis of depression and be within the age range 18 to 65. Aspiring candidates should note that only 24 spots are available."

Answered by AI

What is the extent of the current sample size involved in this clinical investigation?

"Affirmative. As per the information on, this medical trial is currently seeking participants and was initially posted on November 1st 2022. In total, 24 individuals are required to be recruited from a single site before data collection can commence."

Answered by AI

Are there still vacancies in this clinical research for participants?

"Affirmative, has data that shows this trial is still recruiting patients since its initial posting on November 1st 2022. The study requires 24 individuals from one site to take part in the experiment."

Answered by AI

What is the intended outcome of this research endeavor?

"This clinical trial, to be conducted in a two-week baseline period followed by 12 weeks of treatment and 4 weeks follow-up, will measure the weekly change in attentional control. Secondary goals include assessing changes in anxiety severity with PROMIS Item Bank - Emotional Distress - Anxiety - Short Form 8a (which assigns greater score for higher levels of distress) as well as rumination levels measured by the Rumination-Reflection Questionnaire (RRQ)."

Answered by AI
~13 spots leftby Oct 2024